MTBVAC vaccine is safe, immunogenic and confers protective efficacy against Mycobacterium tuberculosis in newborn mice

Development of novel more efficient preventive vaccines against tuberculosis (TB) is crucial to achieve TB eradication by 2050, one of the Millennium Development Goals (MDG) for the current century. MTBVAC is the first and only live attenuated vaccine based on a human isolate of Mycobacterium tuberc...

Descripción completa

Detalles Bibliográficos
Autores principales: Aguilo, Nacho, Uranga, Santiago, Marinova, Dessislava, Monzon, Marta, Badiola, Juan, Martin, Carlos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Churchill Livingstone 2016
Materias:
Model Systems
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4727503/
https://www.ncbi.nlm.nih.gov/pubmed/26786657
http://dx.doi.org/10.1016/j.tube.2015.10.010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4727503/
https://www.ncbi.nlm.nih.gov/pubmed/26786657
http://dx.doi.org/10.1016/j.tube.2015.10.010

Ejemplares similares